Paul Aisen - Concepedia

Author

Paul Aisen

Also Known As

Aisen , P., Aisen, P.S., Aisen, Paul S., Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative (ADNI), Clifford R. Jack, Dan Li, David Perry, For the Alzheimer's Disease Neuroimaging Initiative, H. J. Koch

535

Publications

32.8K

Citations

H-Index

144

Concepts

All Affiliations

University of Southern California University of California San Diego University of California, San Francisco Harvard University Brigham and Women's Hospital

About

Paul Aisen is an author at University of Southern California specializing in medicine, neurology, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	56	3.6K
2	Health Sciences	16	19	983
3	Nursing	2	2	93
4	Education	1	1	74
5	Engineering	1	1	34

Paul Aisen

188

Publications

22.1K

Citations

H-Index

Page 1

	Year	Citations
Alzheimer's Disease Neuroimaging Initiative (ADNI) Ronald C. Petersen, Paul Aisen, Laurel Beckett, Neurology	2009	2.4K
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. Paul Aisen, Kimberly Schafer, Michael Grundman, PubMed	2003	959
The A4 Study: Stopping AD Before Symptoms Begin? Reisa A. Sperling, Dorene M. Rentz, Keith A. Johnson, Science Translational Medicine	2014	754
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease Joseph F. Quinn, Rema Raman, Ronald G. Thomas, JAMA	2010	736
Amyloid deposition, hypometabolism, and longitudinal cognitive decline Susan Landau, Mark A. Mintun, Abhinay D. Joshi, Annals of Neurology	2012	722
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease Raymond Scott Turner, Ronald G. Thomas, Suzanne Craft, Neurology	2015	671
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease Charbel Moussa, Michaeline Hebron, Xu Huang, Journal of Neuroinflammation	2017	671
Comparing predictors of conversion and decline in mild cognitive impairment Susan Landau, Danielle Harvey, Catherine Madison, Neurology	2010	611
High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease Paul Aisen JAMA	2008	544
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease Clifford R. Jack, H. Wiste, Prashanthi Vemuri, Brain AgingNeurochemical BiomarkersLongitudinal NeuroimagingAlzheimer's DiseaseNeurology	2010	522

Page 1